EssilorLuxottica/€EL

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About EssilorLuxottica

EssilorLuxottica, traded under the ticker EL, is a multinational corporation specializing in the design, manufacture, and distribution of ophthalmic lenses, optical equipment, and eyewear. Founded in 2018 through the merger of French company Essilor and Italian company Luxottica, EssilorLuxottica operates in the healthcare sector specifically focusing on eyecare and eyewear products. With a commitment to enhancing visual health, the company combines expertise in lens technology and eyewear design to cater to a global market.

Ticker

€EL

Primary listing

PAR

Industry

Health Care Equipment & Supplies
Headquarters

Employees

153,498

ISIN

FR0000121667

EssilorLuxottica Metrics

BasicAdvanced
€111B
46.92
€5.13
0.92
€3.95
1.64%

What the Analysts think about EssilorLuxottica

Analyst ratings (Buy, Hold, Sell) for EssilorLuxottica stock.

Bulls say / Bears say

EssilorLuxottica reported a 9.4% increase in adjusted operating profit for the previous year, reaching €4.4 billion, with revenues growing 9.2% in Q4, marking the fourth consecutive year of growth. (reuters.com)
The company has sold over 2 million units of Ray-Ban Meta smart glasses since their launch, with plans to increase production capacity to 10 million units annually by the end of next year, indicating strong demand and growth potential in the smart eyewear market. (reuters.com)
Jefferies upgraded EssilorLuxottica's stock to 'Buy' with a price target of €310, citing the company's role as a structural share taker and prime consolidator in the growing optical market, along with innovations in MedTech and digital sectors. (investing.com)
EssilorLuxottica missed third-quarter revenue expectations, reporting €6.44 billion, below analysts' forecasts, due to a slowdown in consumer spending in China and weaker performance in key regions. (usnews.com)
The company plans to raise prices in the U.S. to offset tariffs of up to 36% on products from Thailand and 145% on those from China, which could impact sales volume and consumer demand. (reuters.com)
UBS downgraded EssilorLuxottica's stock to 'Neutral,' suggesting that the market may not fully recognize the company's potential to accelerate top-line growth, and highlighting concerns over margin pressures due to labor inflation. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 22 May 2025.

EssilorLuxottica Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

EssilorLuxottica Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €EL

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs